Financial Health Assessment: REHAU LIMITED

1. Financial Health Score: B+

Explanation: REHAU LIMITED presents as a robust, mature patient with a strong constitutional baseline. The company benefits from a substantial capital foundation and the implied safety net of a global parent entity. However, without the detailed "blood work" (full profit & loss and balance sheet metrics) in this specific dataset, a perfect score cannot be definitively issued. Based on the available structural and compliance vitals, the patient is in excellent shape with no immediate signs of distress.

2. Key Vital Signs

• Pulse & Longevity (Corporate Age & Status): Strong and Steady. Incorporated in 1962, this business has a 60-plus-year track record of survival and adaptation. An "Active" status confirms the heart is still beating, with no signs of terminal decline (liquidation or administration).
• Blood Pressure (Capital & Ownership): Healthy Circulation. With a share capital of £26.9 million, the company has a substantial financial reservoir. Furthermore, the identification of Rehau Verwaltungszentrale AG as the holder of over 75% of shares indicates strong parental backing—acting as a reliable blood transfusion source should the UK entity ever face a liquidity crisis.
• Immune System (Compliance & Filing Health): Robust. The company's filings are completely up to date, with accounts and confirmation statements showing no overdue markers. This indicates a healthy corporate immune system that is highly responsive to regulatory requirements, avoiding the fevers and penalties of late filing.
• Cellular Turnover (Officer & PSC Changes): Normal. The recent resignation of a secretary (April 2026) and the presence of multiple directors and Persons with Significant Control (PSCs) represent normal administrative cell turnover. The board includes international representation, aligning with the global nature of the parent company.
• Respiration (Industry & Operations): Active. Operating in the manufacture of plastic products (SIC 22290) and providing polymer-based solutions globally, the company is breathing steadily in a vital industrial sector.

3. Diagnosis

Based on the visible symptoms and structural indicators, REHAU LIMITED is a healthy, well-capitalized subsidiary of a global manufacturing group. The patient exhibits no external symptoms of financial distress—there are no red flags such as overdue filings, liquidation status, or disqualifications among the directors.

The corporate DNA is particularly noteworthy: the ultimate control resting with the Swiss/German parent group (Rehau Verwaltungszentrale AG) means this entity operates with a significant safety net. While the specific financial blood work (turnover, net current assets, profitability) is kept confidential in this micro-view, the sheer size of the share capital (£26.9m) and the pristine compliance record suggest a business that is well-managed and financially supported from the top down. The historical rebranding (from Rehau Plastiks to Rehau Plastics to Rehau Limited) shows a history of healthy corporate evolution rather than erratic identity changes.

4. Recommendations

To maintain and improve this excellent financial wellness, the following preventative care measures are recommended:

• Cardiovascular Endurance (Cash Flow Monitoring): Even well-capitalized companies must maintain healthy cash flow habits. Continue to monitor working capital ratios closely, ensuring that short-term liabilities do not outpace the cash conversion cycle in the manufacturing process.
• Industry-Specific Preventative Care (Regulatory Compliance): As a plastics manufacturer, the company operates in a sector facing increasing environmental and regulatory pressures. Proactive investment in sustainable polymer solutions and compliance with evolving UK environmental regulations will act as preventative medicine against future legislative "shocks."
• Routine Screenings (Financial Auditing): Given the group structure, ensure that internal audits are conducted regularly. While the parent company provides a safety net, transparent and regular internal check-ups will ensure the UK entity remains a net contributor to the global group's health rather than a dependent.